The Venture Codex Logo

The Venture Codex

Overview

Investment firm supporting independent thinkers from seed to growth stages.

Founded

2021

Deals · 12mo

2

Links

Stage focus

Multi-stage

Geographic focus

United States

Sector focus

Business Development
Finance
Financial Services
Venture Capital

Investment portfolio

  • The American Baby Company

    Led · Seed · Jul 2026

    The American Baby Company is a West Palm Beach–based fertility startup that aims to expand access to IVF through lower-priced clinic offerings. It plans to open its first clinic in West Palm Beach later this year and to offer a full IVF cycle, including medications, for $8,995. The company emphasizes operational execution—clinical staffing, patient experience and payor relationships—to scale care delivery rather than relying solely on software. Its pricing thesis contrasts the $8,995 offering with an average cited single-cycle cost of around $23,500. The startup raised a $4 million seed round led by Wormhole Capital and Tower Research Ventures to fund the clinic launch and related operational buildout. The articles do not disclose revenue, user metrics, or prior funding rounds.

  • Simuhealth

    Participated · Seed · Dec 2025

    Founded in 2024 and based in Vancouver, Simuhealth has built an enterprise resource-planning platform that schedules simulation sessions, tracks equipment and attendance, and generates outcome and resource-usage reports for healthcare trainers. The software replaces fragmented legacy tools and manual processes, enabling hospitals and academic institutions to scale and standardize clinician training programs. Current customers include the Provincial Health Services Authority, Island Health, Interior Health, and Fraser Health. With its workflow and reporting capabilities, the company positions itself as critical infrastructure for ongoing clinical skill development and compliance. The freshly raised capital will support expansion across Canada and into the United States, where it aims to broaden its hospital and academic footprint. Although revenue figures were not disclosed, exceeding its funding target suggests early market traction. Additional non-dilutive support from Canada’s NRC-IRAP will fund deeper technical R&D as the product roadmap evolves.

  • Ema

    Participated · Equity · Feb 2024

    Ema provides a generative AI assistant delivering personalized, empathetic, evidence-based support for women's health, built and trained by licensed health professionals. The platform serves more than 100,000 direct-to-consumer users and has begun scaling into B2B, securing over $100K in contracts within 30 days after a pivot. Medical testers reported strong endorsement, with 97% saying they would recommend Ema. The assistant handles health, mental-health, and parenting questions and guides therapeutic exercises such as journaling, including support for postpartum anxiety. Ema plans to expand into employee benefits to support working women, potentially improving return rates from maternity leave and reducing absenteeism. The company has raised nearly $2 million in total funding and will use the bridge financing to scale product and business integrations.

  • Heidi Health

    Participated · Series A · Oct 2023

    Founded in 2021 by trauma surgeon Dr. Tom Kelly and technologist Waleed Mussa, Heidi Health offers an AI medical scribe that transcribes and dictates notes, creates personalized patient summaries, and tracks follow-up tasks so physicians can focus on care. The platform is model-agnostic, combining the company’s proprietary models with large models such as Gemini to optimize accuracy, latency and cost. Since launching products in early 2024, Heidi Health says it has returned more than 18 million clinical hours across 70 million patient visits in 116 countries and currently serves over 2 million clinicians each week. The company operates on a freemium model, augmenting its core scribe with paid features and, most recently, an AI agent that calls patients on a doctor’s behalf. Future plans center on expanding product capabilities and broadening access to providers in settings ranging from large hospitals to refugee camps. Key new hires include former Microsoft Chief Medical Officer Dr. Simon Kos and Plaid’s head of revenue Paul Williamson. Heidi Health has raised a total of $96.6 million to date to fund its growth and product development.

  • Angle Health

    Participated · Series A · Jan 2023

    Angle Health provides an AI-powered, vertically integrated platform that combines underwriting, claims administration, and member engagement to streamline employer-sponsored health benefits. Its benefit-builder and quote-to-card tools let brokers generate firm underwritten quotes in minutes using only a census and activate groups in real time. The platform connects employers and employees to tailored healthcare plans, aiming to make benefits administration faster and more transparent. Led by CEO Ty Wang, the company plans to use new capital to expand operations and accelerate product development. Angle Health positions itself as a solution for businesses of any size seeking custom benefits packages and a consumer-grade healthcare experience. With the latest financing, the company’s total funding approaches $200 million, underscoring strong investor confidence in its growth trajectory.

Insights

Team